Cargando…

Sjögren’s syndrome with and without neurological involvement

OBJECTIVE: Neurological manifestations of Sjögren’s syndrome can be severe but also treatment-responsive. We aimed to systematically evaluate neurological manifestations of primary Sjögren’s syndrome and find clinical features allowing sufficient identification of affected patients (pSSN) among thos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seeliger, Tabea, Kramer, Emelie, Konen, Franz Felix, Zehrfeld, Nadine, Beider, Sonja, Prenzler, Nils Kristian, Gödecke, Vega, Witte, Torsten, Skripuletz, Thomas, Ernst, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188418/ https://www.ncbi.nlm.nih.gov/pubmed/36802030 http://dx.doi.org/10.1007/s00415-023-11613-5

Ejemplares similares

Premature stroke and cardiovascular risk in primary Sjögren's syndrome
por: Zippel, Clara L., et al.
Publicado: (2022)

Multimodal Assessment and Characterization of Sicca Syndrome
por: Kramer, Emelie, et al.
Publicado: (2021)

Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome
por: Seeliger, Tabea, et al.
Publicado: (2019)

Cognitive impairment in patients with Neuro‐Sjögren
por: Seeliger, Tabea, et al.
Publicado: (2020)

Saliva Free Light Chains in Patients with Neuro-Sjögren
por: Konen, Franz Felix, et al.
Publicado: (2022)

Clinical and paraclinical features of small fiber neuropathy in Sjögren’s syndrome
por: Seeliger, Tabea, et al.
Publicado: (2022)

Trigeminal Nerve Affection in Patients with Neuro-Sjögren Detected by Corneal Confocal Microscopy
por: Seeliger, Tabea, et al.
Publicado: (2022)

Hearing dysfunction in patients with Neuro-Sjögren: a cross-sectional study
por: Seeliger, Tabea, et al.
Publicado: (2020)

Clinical, Radiological, and Laboratory Features of Spinal Cord Involvement in Primary Sjögren’s Syndrome
por: Butryn, Michaela, et al.
Publicado: (2020)

Lung Involvement in Primary Sjögren's Syndrome—An Under-Diagnosed Entity
por: Sogkas, Georgios, et al.
Publicado: (2020)

Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases
por: Konen, Franz Felix, et al.
Publicado: (2022)

Reiber’s Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

Was ist gesichert in der Therapie des systemischen Lupus erythematodes?
por: Gödecke, Vega, et al.
Publicado: (2023)

Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases
por: Möhn, Nora, et al.
Publicado: (2020)

Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditions
por: Gingele, Stefan, et al.
Publicado: (2021)

Leistungsfähigkeit der McDonald-Kriterien von 2017
por: Konen, Franz Felix, et al.
Publicado: (2022)

The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2018)

The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation
por: Konen, Franz Felix, et al.
Publicado: (2020)

Aspects of innate immunity in Sjögren's syndrome
por: Low, Hui Zhi, et al.
Publicado: (2011)

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2022)

Zusammenhang von körperlicher Aktivität mit Fatigue und Funktionskapazität bei Patienten mit rheumatoider Arthritis
por: Beider, S., et al.
Publicado: (2020)

Alzheimer’s disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C
por: Konen, Franz Felix, et al.
Publicado: (2023)

Presence of Antibodies Binding to Negative Elongation Factor E in Sarcoidosis
por: Baerlecken, Niklas, et al.
Publicado: (2020)

Neurological Disorders in Primary Sjögren's Syndrome
por: Tobón, Gabriel J., et al.
Publicado: (2012)

Neurological manifestations of primary Sjögren’s syndrome
por: Perzyńska-Mazan, Joanna, et al.
Publicado: (2018)

Neurological injury in primary Sjogren’s syndrome
por: Khalayli, Naram, et al.
Publicado: (2023)

Versorgung von rheumatologischen Patienten während des Lockdowns im Frühjahr 2020: Telemedizin, Delegation, Patientenzufriedenheit und Impfverhalten
por: Thiele, Thea, et al.
Publicado: (2021)

Neurological Involvement in Patients With Primary Sjögren’s Syndrome
por: Fan, Guihua, et al.
Publicado: (2021)

Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment
por: Süße, Marie, et al.
Publicado: (2022)

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid
por: Konen, Franz F, et al.
Publicado: (2021)

Praktikable Sjögren-Diagnostik bei interstitieller Lungenerkrankung – ein Diskussionsbeitrag
por: Aringer, Martin, et al.
Publicado: (2023)

Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2021)

A rare initial neurological presentation of Sjogren's syndrome
por: Kumar, Srikanteswara Praveen
Publicado: (2015)

Severe Anti-N-Methyl-D-Aspartate Receptor Encephalitis Under Immunosuppression After Liver Transplantation
por: Konen, Franz Felix, et al.
Publicado: (2019)

Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren’s Syndrome
por: Voigt, Alexandria, et al.
Publicado: (2014)

Clinical features and risk factors of neurological involvement in Sjögren’s syndrome
por: Ye, Wenjing, et al.
Publicado: (2018)

Hospitalization Risks for Neurological Disorders in Primary Sjögren’s Syndrome Patients
por: Goulabchand, Radjiv, et al.
Publicado: (2022)

Fulminant Neurologic Manifestation of Sjogren’s Syndrome: A Case Report
por: Laxmidhar, Rosy M, et al.
Publicado: (2023)

Neurological and Inflammatory Manifestations in Sjögren’s Syndrome: The Role of the Kynurenine Metabolic Pathway
por: de Oliveira, Fabíola Reis, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qp2nqpel9ohr5lh6mpik5pmiro